Lux Biosciences, Inc. - Management

return to small text site

electronic press kit

LX212

proprietary technologies

dry eye syndrome

age-related macular degeneration

history

board of directors

Ophthalmic Indications

Products &
Technologies

News & Media

Careers

MANAGEMENT

Dean J. Mitchell
President & Chief Executive Officer

A. Clarke Atwell
Founder, Chief Operating Officer

Eddy Anglade, M.D.
Founder, Chief Medical Officer

© 2009 Lux Biosciences, Inc. All rights reserved. Web Terms Clinical Trials